MAFFEZZOLI, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 78
NA - Nord America 32
AS - Asia 22
AF - Africa 6
Totale 138
Nazione #
IT - Italia 43
US - Stati Uniti d'America 32
IE - Irlanda 23
CN - Cina 19
MA - Marocco 6
SE - Svezia 5
DE - Germania 3
AT - Austria 2
FI - Finlandia 2
IN - India 2
SG - Singapore 1
Totale 138
Città #
Dublin 23
Ashburn 11
Milan 10
Shanghai 10
Parma 8
Beijing 6
Meknes 6
Bologna 5
Aachen 3
Brescia 3
Scandiano 3
Busto Arsizio 2
Los Angeles 2
Pune 2
Sant'Ambrogio di Valpolicella 2
Vienna 2
Castel di Lama 1
Cologno Monzese 1
Desio 1
Helsinki 1
Padova 1
Totale 103
Nome #
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib 34
Real world analysis of peritoneal metastasis from renal cell carcinoma: Meet-Uro 27 study 30
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors 25
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 19
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 18
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 7
Prognostic models for patients with metastatic urothelial carcinoma: why to use them? 7
Prognostication for surgically treated papillary renal cell carcinoma: which model is the optimal choice? 5
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations 2
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27 1
Totale 148
Categoria #
all - tutte 811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202361 0 0 0 0 11 2 5 1 27 0 15 0
2023/202487 0 8 4 3 14 13 13 9 16 7 0 0
Totale 148